Antitumor drug delivery by tissue electroporation

Anti-Cancer Drugs

Volumn 10, Issue 2, 1999, Pages 139-146

  Singh, Brahma N ^a   Dwivedi, Chandradhar ^b  

^a ST JOHN'S UNIVERSITY   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Adjuvant immunotherapy; Anticancer drug; Drug resistance; Electrochemotherapy; Electrogene therapy; Electropermeabilization

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CONGOCIDINE; DACTINOMYCIN; INTERLEUKIN 2;

BRAIN TUMOR; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; EDEMA; ELECTRIC POTENTIAL; ELECTROCHEMOTHERAPY; ELECTROPORATION; ERYTHEMA; HEAD AND NECK CARCINOMA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER CANCER; LUNG CANCER; LUNG TOXICITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER;

EID: 0033061978     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199902000-00001     Document Type: Review

References (64)

1. Neumann E, Sowers AE, Jordan CA, eds. Electroporation and electrofusion. In: Cell Biology. New York: Plenum Press 1989.
2. Chang DC, Chasy BM, Saunders JA, Sowers AE, eds. Guide to Electroporation and Electrofusion. New York: Academic Press 1992.
3. Weaver JC. Electroporation theory: concepts and mechanisms. Methods Mol Biol 1995; 48: 3-28.
4. Rols MP, Teissie J Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 1990; 58: 1089-98.
5. Tsong TY. Electroporation of cell membranes. Biophys J 1991; 60: 297-306.
6. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993; 51: 426-35.
7. Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1993; 1154: 51-63.
8. Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1993; 1190: 155-63.
9. Okino M, Mohri H. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res 1987; 78: 1319-21.
10. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy: potentiation of antitumor effect of bleomycin by local electric pluses. Eur J Cancer 1991; 27: 68-72.
11. Mansouri A, Henle KJ, Nutt AK, Nagle WA. New approaches to the study of tumor drug resistance. SAAS Bull Biochem Biotechnol 1991; 4: 13-6.
12. Heller R. Treatment of cutaneous nodules using electrochemotherapy. J Fla Med Ass. 1995; 82: 147-50.
13. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77: 964-71.
14. Jain RK. Physiological resistance to the treatment of solid tumors. In: Teicher BA, ed. Drug resistance in oncology. New York: Marcel Dekker 1993: 87-105.
15. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 58-65.
16. Weaver JC, Langer R, Potts RO. Tissue electroporation for localized drug delivery. In: Blank M, ed. Advances in chemistry series. Washington, DC: American Chemical Society 1995; 205: 301-16.
17. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727-33.
18. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988; 175: 15-25.
19. Bazile D, Mir LM, Paoletti C. Voltage-dependent introduction of a d-[α] octothymidylate into electropermeabilized cells. Biochem Biophys Res Commun 1989; 159: 633-9.
20. Jaroszeski MJ, Gilbert R, Perrott R, Heller R. Enhanced effects of multiple treatment electrochemotherapy. Melanoma Res. 1996; 6: 427-33.
21. Serša G, Èemaar M, Miklavèiè D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res. 1995; 55: 3450-5.
22. Domenge C, Orlowski S, Luboinski B, et al. Antitumor electrochemtherapy: new advances in the clinical protocol. Cancer 1996; 77: 956-63.
23. Yabushita H, Yoshikawa K, Hirata M, et al. Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. Gynecol Oncol 1997; 65: 297-303.
24. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992; 83: 1095-101.
25. Serša G, Eemaar M, Semrov D, Miklavèiè D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem Bioenerget 1996; 39: 61-6.
26. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997; 1334: 9-14.
27. Serša I, Beravs K, Dodd NJF, Zhao S, Miklavèiè D, Demsar F. Electric current density imaging of mice tumors. Magn Reson Med 1997; 37: 404-9.
28. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 1997; 7: 10-8.
29. Dev SB, Hofmann GA. Electrochemotherapy a novel method of cancer treatment. Cancer Treat Rev 1994; 20: 105-15.
30. Melvik JE, Pettersen EO, Gordon PB, Selgen PO. Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 1986; 22: 1523-30.
31. Nutt AK, Mansouri A, Henle KJ. Response of cisplatin resistant tumor cells to electroporation and cisplatin. Proc Am Ass Cancer Res 1991; 32: 375.
32. Poddevin B, Orlowski S, Belehradek J Jr, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991; 42: S67-75.
33. Yamaguchi O, Irisawa C, Baba K, Ogihara M, Yokota T, Shiraiwa Y. Potentiation of antitumor effect of bleomycin followed by local electric pulses in mouse bladder tumor. Tohoku J Exp Med 1995; 172: 291-3.
34. Tada T, Matsumoto K, Suzuki H. Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice. Surg. Today 1997; 27: 506-10.
35. Dev SB, Nanda GS. Treating pancreatic cancers: is the combination of chemotherapy with pulsed electric field the answer? Proc Am Ass Cancer Res 1996; 37: A2054.
36. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumors in mice. Eur J Cancer 1991; 27: 73-6.
37. Heller R, Jaroszeski M, Leo-Messina J, et al. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem Bioenerget 1995; 36: 83-7.
38. Okino M, Esato K. The effects of a single high voltage electrical stimulation with an anticancer drug on in vivo growing malignant tumors. Jpn J Surg 1990; 20: 197-204.
39. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma in vivo (in Japanese, abstract and tables in English). J Jpn Soc Cancer Ther 1990; 25: 2640-8.
40. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PC, Mir LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 1993; 194: 938-43.
41. Zaroszeski MJ, Gilbert RA, Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1997; 1334: 15-8.
42. Glass LF, Fenske NA, Jaroszeski M, et al. Bleomycin-mediated electrochemotherapy of basal-cell carcinoma. J Am Acad Dermatol 1996; 34: 82-6.
43. Mir LM, Relehradek M, Domenge C, et al. Electrochemotherapy, a new antitumor treatment: first clinical trial (in French, abstract in English). C R Acad Sci III 1991; 313: 613-8.
44. Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS, Heller R. Bleomycin mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996; 132: 1353-7.
45. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of hosts defenses. Eur Cytokine Netw 1992; 3: 331-4.
46. Serša G, Kotnik V, Èemaar M, Miklavèiè D, Kotnik A. Electrochemotherapy with bleomycin in SA-1 tumor hearing mice: natural resistance and immune responsiveness. Anti-Cancer Drugs 1996; 7: 785-91.
47. Quintin-Colonna F, Devauchelle P, Fradelizi D, et al. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin 2. Gene Therapy 1996; 3: 1104-12.
48. Mir LM, Roth C, Orlowski S, et al. Potentiation of the antitumor effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin 2. C R Acad Sci III 1992; 314: 539-44.
49. Mir LM, Roth C, Orlowski S, et al. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol 1995; 17: 30-8.
50. Serša G, Èemaar M, Menart V, Gaberc-Porekar V, Miklavèiè D. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. Cancer Lett 1997; 116: 85-92.
51. 2+. Bioelectrochem Bioenerget 1982; 9: 149-55.
52. Sukharev SI, Titomirov AV, Klenchin VA. Electrically-induced DNA transfer into cells. Electrotransfection in vivo. In: Wolff JA, ed. Gene therapeutics. Boston: Birkhaüser 1994: 210-32.
53. Oellig C, Seliger B. Gene transfer into brain tumor cell lines: reporter gene expression using various cellular and viral promotors. J Neurosci Res 1990; 26: 390-6.
54. Knutson JC, Yee D. Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal Biochem 1987; 164: 44-52.
55. Nishi T, Yoshizato K, Yamashiro S, et al. High efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in-vivo electroporation. Cancer Res 1996; 56: 1050-5.
56. Heller R, Jaroszeski M, Atkin A, et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389: 225-8.
57. Mir LM, Orlowski S, Belehradek J Jr, et al. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectrochem Bioenerget 1995; 38: 203-7.
58. Huang LR, Xie Y, Lown JW. Bleomycin antibiotics and their role in cancer chemotherapy. Expert Opin Ther Patents 1996; 6: 893-9.
59. Serša G, Èemaar M, Miklavèiè D, Mir LM. Electrochemotherapy: variable antitumor effect on different tumor models. Bioelectrochem Bioenerget 1994; 35: 23-7.
60. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 2: 3694-700.
61. Ramirez LH, Bognel C, Zhao ZX, et al. Electrochemotherapy: preclinical data on normal tissue tolerance and antitumor effects in rabbits. Proc Am Ass Cancer Res 1994; 35: A1969.
62. Devauchelle P, Quintin-Colonna F, Delisle F, et al. Treatment of cat fibrosarcoma by electrochemotherapy. Proc Am Ass Cancer Res 1995; 36: A1835.
63. Mir LM, Orlowski S, Belehradek J Jr, et al. Electrochemotherapy: a new antitumor treatment using electric pulses. In: Blank M ed. Electricity and magnetism in biology and medicine. San Francisco, CA: San Francisco Press 1993: 119-21.
64. Nishi T, Dev SB, Yoshizato K, Kuratsu J, Ushio Y. Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes. Hum Cell 1997; 10: 81-6.